Clinical-stage biotech developing leronlimab, a monoclonal antibody targeting CCR5 for oncology and inflammatory diseases.
Get notified the moment CytoDyn Inc. (CYDY) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.